Several works describe biomarkers and signatures for assessment of colorectal cancer prognosis based on the expression of particular genes involved in ECM–receptor interaction, including genes encoding integrins (Boudjadi et al., 2013; Gong et al., 2019), E- and P-cadherin (Sun et al., 2011; Christou et al., 2017), and different laminins (Galatenko et al., 2018). The gene discussed is LAMB2; the disease is colorectal cancer.